Medizinonline Medizinonline
  • News
    • News
    • Market & Medicine
  • Patients
    • Disease patterns
    • Diagnostics
    • Therapy
  • Partner Content
    • Dermatology
      • Atopic dermatitis and psoriasis news
      • Dermatology News
    • Diabetes
      • Dia-Month Club – Type 2 Diabetes
      • Diabetes in Motion
      • Diabetes Podcasts
    • Gastroenterology
      • IBD matters
      • Forum Gastroenterology
      • Ozanimod: ulcerative colitis
      • Reflux Update
    • Immunology
      • Primary immunodeficiency – exchange of experience
    • Vaccinate
      • Herpes zoster
    • Infektiologie
    • Neurology
      • EXPERT ULTRASONIC: Introduction to ultrasound-guided injection
      • MS News
      • MS Therapy in Transition
    • Oncology
      • Swiss Oncology in motion
    • Orthopedics
      • Osteoporosis in motion
    • Phytotherapie
    • Practice Management
      • Aargau Cantonal Bank
      • Claraspital
    • Psychiatry
      • Geriatric Psychiatry
    • Rheumatology
  • Departments
    • Allergology and clinical immunology
    • General Internal Medicine
    • Anesthesiology
    • Angiology
    • Surgery
    • Dermatology and venereology
    • Endocrinology and Diabetology
    • Nutrition
    • Gastroenterology and Hepatology
    • Genetics
    • Geriatrics
    • Gynecology
    • Hematology
    • Infectiology
    • Cardiology
    • Nephrology
    • Neurology
    • Emergency and intensive care medicine
    • Nuclear Medicine
    • Oncology
    • Ophthalmology
    • ORL
    • Orthopedics
    • Pediatrics
    • Pharmacology and toxicology
    • Pharmaceutical medicine
    • Phlebology
    • Physical medicine and rehabilitation
    • Pneumology
    • Prevention and health care
    • Psychiatry and psychotherapy
    • Radiology
    • Forensic Medicine
    • Rheumatology
    • Sports Medicine
    • Traumatology and trauma surgery
    • Tropical and travel medicine
    • Urology
    • Dentistry
  • CME & Congresses
    • CME continuing education
    • Congress Reports
    • Congress calendar
  • Practice
    • Noctimed
    • Practice Management
    • Jobs
    • Interviews
  • Log In
  • Register
  • My account
  • Contact
  • English
    • Deutsch
    • Français
    • Italiano
    • Português
    • Español
  • Publications
  • Contact
  • Deutsch
  • English
  • Français
  • Italiano
  • Português
  • Español
Subscribe
Medizinonline Medizinonline
Medizinonline Medizinonline
  • News
    • News
    • Market & Medicine
  • Patienten
    • Krankheitsbilder
    • Diagnostik
    • Therapie
  • Partner Content
    • Dermatology
      • Atopic dermatitis and psoriasis news
      • Dermatology News
    • Diabetes
      • Dia-Month Club – Type 2 Diabetes
      • Diabetes in Motion
      • Diabetes Podcasts
    • Gastroenterology
      • IBD matters
      • Forum Gastroenterology
      • Ozanimod: ulcerative colitis
      • Reflux Update
    • Immunology
      • Primary immunodeficiency – exchange of experience
    • Vaccinate
      • Herpes zoster
    • Infektiologie
    • Neurology
      • EXPERT ULTRASONIC: Introduction to ultrasound-guided injection
      • MS News
      • MS Therapy in Transition
    • Oncology
      • Swiss Oncology in motion
    • Orthopedics
      • Osteoporosis in motion
    • Phytotherapie
    • Practice Management
      • Aargau Cantonal Bank
      • Claraspital
    • Psychiatry
      • Geriatric Psychiatry
    • Rheumatology
  • Departments
    • Fachbereiche 1-13
      • Allergology and clinical immunology
      • General Internal Medicine
      • Anesthesiology
      • Angiology
      • Surgery
      • Dermatology and venereology
      • Endocrinology and Diabetology
      • Nutrition
      • Gastroenterology and Hepatology
      • Genetics
      • Geriatrics
      • Gynecology
      • Hematology
    • Fachbereiche 14-26
      • Infectiology
      • Cardiology
      • Nephrology
      • Neurology
      • Emergency and intensive care medicine
      • Nuclear Medicine
      • Oncology
      • Ophthalmology
      • ORL
      • Orthopedics
      • Pediatrics
      • Pharmacology and toxicology
      • Pharmaceutical medicine
    • Fachbereiche 26-38
      • Phlebology
      • Physical medicine and rehabilitation
      • Phytotherapy
      • Pneumology
      • Prevention and health care
      • Psychiatry and psychotherapy
      • Radiology
      • Forensic Medicine
      • Rheumatology
      • Sports Medicine
      • Traumatology and trauma surgery
      • Tropical and travel medicine
      • Urology
      • Dentistry
  • CME & Congresses
    • CME continuing education
    • Congress Reports
    • Congress calendar
  • Practice
    • Noctimed
    • Practice Management
    • Jobs
    • Interviews
Login

Sie haben noch keinen Account? Registrieren

  • Severe COVID-19 courses

Which lung patients need special protection

    • Infectiology
    • News
    • Pneumology
    • RX
  • 2 minute read

Most people who become infected with the new SARS-CoV-2 coronavirus do not become severely ill. However, patients with chronic respiratory and pulmonary diseases are particularly confused. The German Society for Pneumology and Respiratory Medicine (DGP) has issued a recent statement on which of these patients have a higher risk of severe disease progression.

In the majority of patients affected by COVID-19, the course of the disease is mild to moderate and symptoms are present for an average of 11.5 days after infection. According to the Robert Koch Institute, eight to ten percent of COVID-19 patients are hospitalized in Germany. “This figure probably still overestimates the proportion of severe cases, since especially at the beginning of the pandemic not only the severity of the disease, but partly also the necessary isolation was the reason for admission,” says Professor Torsten Bauer, MD, Deputy DGP President. “This is reflected in the relatively low proportion of intensive care treatments of only eight percent of these hospitalized cases.” The current estimated probability of dying from COVID-19 is less than one percent (based on the estimated total of all infected persons), according to currently available data. However, mortality rates vary considerably depending on the age group. Thus, older patients are more frequently affected than younger ones.

Many patients with chronic respiratory and pulmonary diseases, such as asthma or COPD, are concerned about the current pandemic and fear they are more at risk from SARS-CoV-2 than healthy individuals. “Patients want the best possible protection against infection,” said Professor Marek Lommatzsch, MD, senior physician at the Department of Pneumology at the University of Rostock and speaker of the German Lung Conference. “But physicians, who have a duty to provide appropriate and meaningful protective measures to their patients, are also confused.” Therefore, risk assessment is of particular importance for patient groups with pre-existing respiratory and pulmonary diseases.

COPD patients at higher risk

In the paper, “Risk Assessment in Patients with Chronic Respiratory and Pulmonary Diseases in the Context of the SARS-CoV-2 Pandemic,” DGP experts assess the risk of certain patient groups (for example, those with asthma, COPD, lung cancer, or sleep apnea) to suffer a severe COVID-19 illness and explain which patient groups need special protection. For example, well-treated patients with asthma are not at increased risk for severe COVID-19 courses. The situation is different for people with COPD: “From the data available so far, there are indications that patients with COPD have a higher risk of severe COVID-19 courses. In the presence of cardiovascular comorbidity, patients with COPD can be assumed to have a significantly increased risk,” explains Lommatzsch.

Experts advise all patients with chronic respiratory and pulmonary diseases to strictly follow the recommendations of the Robert Koch Institute. In particular, the distance requirements, hygiene rules and vaccination recommendations should be observed. The complete recommendations of the DGP can be found on the website of the professional society. They are regularly updated based on the daily new findings on COVID-19: https://pneumologie.de/aktuelles-service/covid-19/

Source: German Society for Pneumology and Respiratory Medicine (DGP)

 

InFo PNEUMOLOGY & ALLERGOLOGY 2020; 2(2): 4 (published 6/18/20, ahead of print).

Autoren
  • Jens Dehn
Publikation
  • InFo PNEUMOLOGIE & ALLERGOLOGIE
Related Topics
  • Asthma
  • COPD
  • CORONA
  • covid
  • sars-cov-2
Previous Article
  • Skin aging processes

What role do antioxidants play in anti-aging?

  • Dermatology and venereology
  • Education
  • Nutrition
  • Prevention and health care
  • RX
View Post
Next Article
  • SARS-CoV-2

What next? Coping strategies and future scenarios

  • Congress Reports
  • Infectiology
  • News
  • Prevention and health care
  • RX
View Post
You May Also Like
View Post
  • 5 min
  • Asthma in adults

When do pneumology specialists come into play?

    • RX
View Post
  • 10 min
  • Cutaneous lupus erythematosus

From diagnostic workup to successful treatment

    • Congress Reports
    • Dermatology and venereology
    • RX
    • Studies
View Post
  • 4 min
  • Guideline update

Dietary recommendations for Crohn’s disease and colitis

    • Education
    • Gastroenterology and Hepatology
    • General Internal Medicine
    • Nutrition
    • RX
    • Studies
View Post
  • 4 min
  • Circadian rhythm during Ramadan

Disturbed sleep patterns lead to metabolic stress

    • Education
    • Endocrinology and Diabetology
    • General Internal Medicine
    • Nutrition
    • RX
    • Studies
View Post
  • 6 min
  • Case Report

Breast cancer metastases in the bladder

    • Cases
    • Education
    • Gynecology
    • Oncology
    • RX
    • Urology
View Post
  • 11 min
  • Findings from the ALS Symposium 2024 in Montreal

Current and future approaches in the treatment of amyotrophic lateral sclerosis (ALS)

    • Congress Reports
    • Interviews
    • Neurology
    • RX
    • Studies
View Post
  • 8 min
  • Efficacy, mechanism of action and clinical effects

Garlic and high blood pressure

    • Cardiology
    • Education
    • General Internal Medicine
    • Pharmaceutical medicine
    • Phytotherapy
    • RX
    • Studies
View Post
  • 7 min
  • Moderate to severe chronic hand eczema

Delgocitinib cream – first topical pan-JAK inhibitor approved in Switzerland

    • Allergology and clinical immunology
    • Dermatology and venereology
    • Education
    • Infectiology
    • Market & Medicine
    • Pharmacology and toxicology
    • RX
Top Partner Content
  • Forum Gastroenterology

    Zum Thema
  • Herpes zoster

    Zum Thema
  • Dermatology News

    Zum Thema
Top CME content
  • 1
    Patience, knowledge and persistence in therapy
  • 2
    Sarcopenia and malnutrition in the context of pneumological rehabilitation
  • 3
    Medical and psychosocial perspectives
  • 4
    New nomenclature for non-alcoholic fatty liver disease
  • 5
    Examinations and considerations before therapy

Newsletter

Sign up and stay up to date

Subscribe
Medizinonline
  • Contact
  • General terms and conditions
  • Imprint

Input your search keywords and press Enter.